Last $2.69 USD
Change Today -0.01 / -0.37%
Volume 167.7K
UPI On Other Exchanges
As of 8:10 PM 07/21/14 All times are local (Market data is delayed by at least 15 minutes).

uroplasty inc (UPI) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/24/14 - $5.40
52 Week Low
07/22/13 - $1.70
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for UROPLASTY INC (UPI)

Related News

No related news articles were found.

uroplasty inc (UPI) Related Businessweek News

No Related Businessweek News Found

uroplasty inc (UPI) Details

Uroplasty, Inc., a medical device company, develops, manufactures, and markets products for the treatment of voiding dysfunctions primarily in the United States. It principally offers Urgent PC Neuromodulation system, a minimally-invasive, neuromodulation system that delivers percutaneous tibial nerve stimulation for office-based treatment of overactive bladder and the associated symptoms of urinary urgency, urinary frequency, and urge incontinence. The company also provides Macroplastique implants, an injectable and urethral bulking agent for the treatment of adult female stress urinary incontinence due to intrinsic sphincter deficiency, as well as for the treatment of male stress incontinence, fecal incontinence, vocal cord rehabilitation, and vesicoureteral reflux. In addition, it offers Macroplastique products for treatment of vesicoureteral reflux; Urgent PC System for the treatment of fecal incontinence; PTQ Implants, which provides a minimally-invasive, soft-textured permanent implant for treatment of fecal incontinence; and VOX Implants, a silicone elastomer bulking material for vocal cord rehabilitation applications, as well as distributes wound care products. The company sells its products primarily to urologists, urogynecologists, and gynecologists through a direct sales organization in the United Kingdom, the Netherlands, Switzerland, and the Nordic countries, as well as through distributors in other markets. Uroplasty, Inc. was incorporated in 1992 and is headquartered in Minnetonka, Minnesota.

113 Employees
Last Reported Date: 06/9/14
Founded in 1992

uroplasty inc (UPI) Top Compensated Officers

Vice President of Corporate Development
Total Annual Compensation: $195.1K
Vice President of Global Marketing
Total Annual Compensation: $205.1K
Compensation as of Fiscal Year 2013.

uroplasty inc (UPI) Key Developments

Uroplasty, Inc. Presents at JMP Securities Healthcare Conference, Jun-24-2014 01:00 PM

Uroplasty, Inc. Presents at JMP Securities Healthcare Conference, Jun-24-2014 01:00 PM. Venue: The Westin New York Grand Central, 212 East 42nd Street, New York, NY 10017, United States. Speakers: Robert E. Kill, Chairman, Chief Executive Officer and President.

Uroplasty Strengthens Board of Directors with Addition of Kevin H. Roche as Chair the Nominating Committee and as a Member of Audit Committee

Uroplasty, Inc. announced that Kevin H. Roche has been appointed to the Company's Board of Directors effective May 29, 2014. Mr. Roche will chair the Nominating Committee and also serve as a member of Uroplasty's Audit Committee. Mr. Roche's background includes more than 30 years in legal, advisory, and executive operating roles within the healthcare industry. He previously served as the General Counsel of UnitedHealth Group, later becoming CEO of their Ingenix division. He currently leads Roche Consulting, LLC.

Uroplasty, Inc. Announces End of Term of Susan Hartjes Holman, Senior Vice President of Operations and Regulatory Affairs, Effective June 21, 2014

Uroplasty, Inc. announced that the terms of the employment agreement effective as of December 7, 1999 between the company and Susan Hartjes Holman, senior vice president of operations and regulatory affairs, the company notified Ms. Holman that her employment with the company will end on June 21, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UPI:US $2.69 USD -0.01

UPI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bacterin International Holdings Inc $0.66 USD 0.00
Cardica Inc $1.14 USD +0.04
Stereotaxis Inc $3.36 USD +0.11
Urologix Inc $0.17 USD -0.01
Vision Sciences Inc/DE $1.09 USD -0.0501
View Industry Companies

Industry Analysis


Industry Average

Valuation UPI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.3x
Price/Book 4.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UROPLASTY INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at